Other psychoactive substance dependence, in remission
ICD-10 F19.21 is a billable code used to indicate a diagnosis of other psychoactive substance dependence, in remission.
F19.21 refers to a diagnosis of dependence on psychoactive substances other than alcohol, opioids, or cannabis, which is currently in remission. This condition indicates that the individual has previously met the criteria for substance dependence but is no longer exhibiting symptoms or behaviors associated with active substance use. Remission can be partial or full, depending on the absence of specific symptoms such as cravings, withdrawal, or continued use despite negative consequences. Treatment for individuals with this diagnosis often includes behavioral therapies, counseling, and support groups aimed at maintaining sobriety and preventing relapse. It is crucial for healthcare providers to document the history of substance use, the duration of remission, and any ongoing treatment or support mechanisms in place to ensure accurate coding and appropriate care management.
Detailed history of substance use, treatment plans, and progress notes.
Patients transitioning from active use to remission, relapse prevention strategies.
Ensure clear documentation of remission status and any ongoing support or therapy.
Comprehensive psychiatric evaluations, treatment history, and mental health assessments.
Patients with co-occurring mental health disorders and substance dependence.
Document any psychiatric interventions and their relation to substance use.
Used for patients in remission from tobacco dependence seeking counseling.
Document the patient's history of tobacco use and current cessation efforts.
Ensure that the counseling aligns with the patient's remission status.
In remission indicates that the individual has previously met the criteria for substance dependence but is currently not exhibiting symptoms or behaviors associated with active substance use. This can be partial or full remission.
